Oncolytic activity of the rhabdovirus VSV‐GP against prostate cancer

Oncolytic viruses, including the oncolytic rhabdovirus VSV‐GP tested here, selectively infect and kill cancer cells and are a promising new therapeutic modality. Our aim was to study the efficacy of VSV‐GP, a vesicular stomatitis virus carrying the glycoprotein of lymphocytic choriomeningitis virus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbiola, Carles, Santer, Frédéric R., Petersson, Monika, van der Pluijm, Gabri, Horninger, Wolfgang, Erlmann, Patrik, Wollmann, Guido, Kimpel, Janine, Culig, Zoran, von Laer, Dorothee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712949/
https://www.ncbi.nlm.nih.gov/pubmed/29696636
http://dx.doi.org/10.1002/ijc.31556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712949/
https://www.ncbi.nlm.nih.gov/pubmed/29696636
http://dx.doi.org/10.1002/ijc.31556

Ejemplares similares